Based on this mechanism, tripolyphosphate (TPP)-siHAT1 nanoparticles have been developed to inhibit HAT1 expression and overcome gemcitabine resistance in pancreatic cancer cells. The gene discussed is HAT1; the disease is familial pancreatic carcinoma.